Repurpose.AI
Repurpose.AI finds new therapeutic uses for previously failed drug candidates to address rare diseases. The company uses an AI-driven computational platform that predicts novel mechanisms of action and prioritizes repurposing opportunities for existing assets. It combines cheminformatics and biological data modeling to match compounds to disease biology and guide preclinical development decisions. Repurpose.AI operates as a B2B biotech and drug-discovery platform, partnering with pharmaceutical companies and academic groups to advance prioritized candidates toward clinical development.
Repurpose.AI
Repurpose.AI finds new therapeutic uses for previously failed drug candidates to address rare diseases. The company uses an AI-driven computational platform that predicts novel mechanisms of action and prioritizes repurposing opportunities for existing assets. It combines cheminformatics and biological data modeling to match compounds to disease biology and guide preclinical development decisions. Repurpose.AI operates as a B2B biotech and drug-discovery platform, partnering with pharmaceutical companies and academic groups to advance prioritized candidates toward clinical development.